Key result
Estrogen therapy in a 67-year-old man with familial hypercholesterolemia and prostatic cancer was associated with a reduction in serum lipoprotein(a).
Why the study?
Does estrogen therapy reduce serum Lipoprotein(a) in a patient with familial hypercholesterolemia?
Case Report (n=1)
Does estrogen therapy reduce serum Lipoprotein(a) in a patient with familial hypercholesterolemia?
Estrogen therapy may reduce serum Lipoprotein(a) levels, offering potential insights into the mechanisms of Lp(a) catabolism.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Takaki Hiraga (1992) conducted a case report in Familial hypercholesterolemia and prostatic cancer (n=1). Estrogen therapy was evaluated on Changes in serum lipids, including Lp(a). Estrogen therapy in a 67-year-old man with familial hypercholesterolemia and prostatic cancer was associated with a reduction in serum lipoprotein(a).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: